Establishing a standard method for analysing case detection delay in leprosy using a Bayesian modelling approach.

Journal Information

Full Title: Infect Dis Poverty

Abbreviation: Infect Dis Poverty

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"additional file 2 : table s1). psis revealed that all data"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateEthical approval for the PEP4LEP study was obtained from the national ethical committees of Ethiopia (MoSHE/RD/4-1/1011/20), Mozambique (476/CNBS/21) and Tanzania (NIMR/HQ/R.8c/Vol.1/1530). The project has been registered at the Netherlands Trial Register under the number Trial NL7294 (NTR7503). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The PEP4LEP project is part of the EDCTP2 programme supported by the European Union awarded to NLR/LM (grant number RIA2017NIM-1839-PEP4LEP), and the Leprosy Research Initiative (LRI; www.leprosyresearch.org) awarded to NLR/LM (grant number 707.19.58.). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript."

Evidence found in paper:

"Declarations: Ethics approval and consent to participateEthical approval for the PEP4LEP study was obtained from the national ethical committees of Ethiopia (MoSHE/RD/4-1/1011/20), Mozambique (476/CNBS/21) and Tanzania (NIMR/HQ/R.8c/Vol.1/1530). The project has been registered at the Netherlands Trial Register under the number Trial NL7294 (NTR7503).: Consent for publicationNot applicable.: Competing interestsThe authors declare that they have no competing interests. Ethics approval and consent to participate: Ethical approval for the PEP4LEP study was obtained from the national ethical committees of Ethiopia (MoSHE/RD/4-1/1011/20), Mozambique (476/CNBS/21) and Tanzania (NIMR/HQ/R.8c/Vol.1/1530). The project has been registered at the Netherlands Trial Register under the number Trial NL7294 (NTR7503)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025